These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 17306997

  • 1. Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma.
    Kiratli H, Kocabeyoğlu S, Bilgiç S.
    J AAPOS; 2007 Aug; 11(4):404-5. PubMed ID: 17306997
    [Abstract] [Full Text] [Related]

  • 2. Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma.
    Shah PK, Kalpana N, Narendran V, Ramakrishnan M.
    Indian J Ophthalmol; 2011 Aug; 59(1):49-51. PubMed ID: 21157073
    [Abstract] [Full Text] [Related]

  • 3. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I, Hubbard GB, Kang SJ, Aaberg TM, Grossniklaus HE.
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH, Frank CM, Dunkel IJ.
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [Abstract] [Full Text] [Related]

  • 5. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW, Yau JW, Moshfeghi D, Fishman M.
    J Pediatr Ophthalmol Strabismus; 2010 May 21; 47 Online():e1-4. PubMed ID: 21214147
    [Abstract] [Full Text] [Related]

  • 6. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
    Mulvihill A, Budning A, Jay V, Vandenhoven C, Heon E, Gallie BL, Chan HS.
    Arch Ophthalmol; 2003 Aug 21; 121(8):1120-4. PubMed ID: 12912689
    [Abstract] [Full Text] [Related]

  • 7. In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.
    Kalita D, Shome D, Jain VG, Chadha K, Bellare JR.
    Am J Ophthalmol; 2014 May 21; 157(5):1109-15. PubMed ID: 24503408
    [Abstract] [Full Text] [Related]

  • 8. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ, Pulido JS, Salomão DR, Smith BD, Mohney B.
    Br J Ophthalmol; 2012 Aug 21; 96(8):1073-7. PubMed ID: 22368261
    [Abstract] [Full Text] [Related]

  • 9. What do we know about intraocular carboplatin?
    Kang KB, Francis JH, Abramson DH.
    J Ocul Pharmacol Ther; 2014 Nov 21; 30(9):688-90. PubMed ID: 25188831
    [No Abstract] [Full Text] [Related]

  • 10. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM, Grossniklaus HE, Edelhauser HF, O'Brien JM.
    Ophthalmology; 2005 Jun 21; 112(6):1151-8. PubMed ID: 15885791
    [Abstract] [Full Text] [Related]

  • 11. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.
    Marr BP, Dunkel IJ, Linker A, Abramson DH.
    Br J Ophthalmol; 2012 Jun 21; 96(6):881-3. PubMed ID: 22328819
    [Abstract] [Full Text] [Related]

  • 12. Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma.
    Astudillo PP, Durairaj P, Chan HS, Héon E, Gallie BL.
    J AAPOS; 2015 Feb 21; 19(1):86-7. PubMed ID: 25727598
    [Abstract] [Full Text] [Related]

  • 13. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.
    Pediatr Blood Cancer; 2013 May 21; 60(5):766-70. PubMed ID: 23024125
    [Abstract] [Full Text] [Related]

  • 14. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb 21; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 15. Periocular chemotherapy for retinoblastoma: success with problems?
    Abramson DH.
    Arch Ophthalmol; 2005 Jan 21; 123(1):128-9; author reply 129. PubMed ID: 15642840
    [No Abstract] [Full Text] [Related]

  • 16. No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma.
    Yousef YA, Halliday W, Chan HS, Héon E, Gallie BL, Dimaras H.
    Can J Ophthalmol; 2013 Dec 21; 48(6):524-8. PubMed ID: 24314416
    [Abstract] [Full Text] [Related]

  • 17. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
    Hayden BH, Murray TG, Scott IU, Cicciarelli N, Hernandez E, Feuer W, Fulton L, O'Brien JM.
    Arch Ophthalmol; 2000 Nov 21; 118(11):1549-54. PubMed ID: 11074812
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar 21; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 19. Assessment of hearing in very young children receiving carboplatin for retinoblastoma.
    Smits C, Swen SJ, Theo Goverts S, Moll AC, Imhof SM, Schouten-van Meeteren AY.
    Eur J Cancer; 2006 Mar 21; 42(4):492-500. PubMed ID: 16376542
    [Abstract] [Full Text] [Related]

  • 20. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb 21; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.